Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infection

American Journal of Pathology

Volumn 149, Issue 1, 1996, Pages 177-185

  Schlaifer, Daniel ^a   Krajewski, Stanislaw ^c   Galoin, Sandrine ^b   Rigal Huguet, Françoise ^a   Laurent, Guy ^a   Massip, Patrice ^c   Pris, Jacques ^a   Delsol, Georges ^b   Reed, John C ^c   Brousset, Pierre ^b  

^a Service d'Hématologie   (France)

^b CHU PURPAN   (France)

^c CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; GENE EXPRESSION; HAIRY CELL LEUKEMIA; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; T CELL LYMPHOMA;

APOPTOSIS; CYTOPLASM; HIV SERONEGATIVITY; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 8944233356     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Wyllie AH, Kerr JFR, Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 1980, 68:251-306
2. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994, 124:1-6
3. Williams GT, Smith CA: Molecular regulation of apoptosis: genetic controls on cell death. Cell 1993, 74:777-779
4. Pezzella F, Gatter K: What is the value of Bcl-2 protein detection for histopathologists? Histopathology 1995, 26:89-93
5. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993, 74:609-619
6. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW: MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci USA 1993, 90:3516-3520
7. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993, 74:597-608
8. Reynolds JE, Yang T, Qian L, Jenkinson JD, Zhou P, Eastman A, Craig RW: Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-myc overexpression in Chinese hamster ovary cells. Cancer Res 1994, 54:6348-6352
9. Schleifer D, March M, Krajewski S, Laurent G, Pris J, Delsol G, Reed JC, Brousset P: High expression of the bcl-x gene in Reed-Sternberg cells of Hodgkin's disease. Blood 1995, 85:2671-2674
10. Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M, Reed JC: Immunohistochemical analysis of Mcl-1 and bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol 1994, 145:515-525
11. Krajewski S, Blomqvist C, Franssila K, Krajewska M, Wasenius V-M, Niskanen E, Nordling S, Reed JC: Reduced expression of pro-apoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastasis breast adenocarcinomas. Cancer Res 1995, 55:4471-4478
12. Krajewski S, Krajewska M, Shabaik A, Wang HG, Irie S, Fong L, Reed JC: Immunohistochemical analysis of in vivo patterns of bcl-x expression. Cancer Res 1994, 54:5501-5507
13. Imamura J, Miyoshi I, Koeffler HP: P53 in hematologic malignancies. Blood 1994, 84:2412-2421
14. Schlaifer D, Brousset P, Attal M, Massip P, Payen C, Marchou B, Huguet F, Muller C, Laurent G, Pris J, Delsol G: Bcl-2 proto-oncogene and Epstein-Barr virus latent membrane protein-1 expression in AIDS-related lymphoma. Histopathology 1994, 25:77-82
15. Brousset P, Butet V, Chittal S, Selves J, Delsol G: Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody. Lab Invest 1992, 67:457-464
16. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994, 84: 1361-1392
17. Pezzella F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY: Expression of the bcl-2 oncogene protein is not specific for the 14; 18 chromosomal translocation. Am J Pathol 1990, 137:225-232
18. Vojtesek B, Bartek J, Midgley CA, Lane DP: An immunohistochemical analysis of the human nuclear phosphoprotein p53: new monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 1992, 151:237-244
19. Hamilton-Dutoit SJ, Raphael M, Audouin J, Diebold J, Lisse I, Pedersen C, Oksenhendler E, Marelle L, Pallesen G: In situ demonstration of Epstein-Barr virus small RNAs (EBER1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood 1993, 82:619-624
20. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991, 65:1107-1115
21. Oltvai ZN, Korsmeyer SJ: Checkpoints of dueling dimers foil death wishes. Cell 1994, 79:189-192
22. Xerri L, Parc P, Brousset P, Schlaifer D, Hassoun J, Reed JC, Krajewski S, Birnbaum D: Predominant expression of the long isoform of Bcl-x (Bcl-xL) in human lymphomas. Br J Haematol 1995 (in press)
23. Krajewski S, Krajewska M, Bodrug S, Fong L, Gascoyne R, Shabaik A, Reed JC: Immunohistochemical mapping of the in vivo patterns of bax, bcl-x, Mcl-1, and bcl-2 protein production. Proc Am Assoc Cancer Res 1995, 36:9
24. Prokocimer M, Rotter V: Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic lineages. Blood 1994, 84:2391-2411
25. Nakamura H, Said JW, Miller CW, Koeffler HP: Mutation and protein expression of p53 in acquired immunodeficiency syndrome-related lymphomas. Blood 1993, 82:920-926
26. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B: Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995, 55: 237-241
27. Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM: Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 1994, 54:2095-2097
28. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human Bax gene. Cell 1995, 80:293-299
29. Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA, Reed JC: Cloning and functional analysis of BAG-1: a novel bcl-2-binding protein with anti-cell death activity. Cell 1995, 80:279-284
30. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ: Bad, a heterodimeric partner for bcl-xL and bcl-2, displaces bax and promotes cell death. Cell 1995, 80:285-291
31. Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B, D'Sa-Eipper C, Chinnadural G Adenovirus E1B 19kDa and Bcl-2 proteins interact with a common set of cellular proteins Cell 1994, 79: 341-351
32. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC: Induction of apoptosis by the Bcl-2 homologue Bak. Nature 1995, 374:733-736